313 related articles for article (PubMed ID: 26877236)
21. Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
Obinata D; Takayama K; Fujiwara K; Suzuki T; Tsutsumi S; Fukuda N; Nagase H; Fujimura T; Urano T; Homma Y; Aburatani H; Takahashi S; Inoue S
Oncogene; 2016 Dec; 35(49):6350-6358. PubMed ID: 27270436
[TBL] [Abstract][Full Text] [Related]
22. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.
Li Y; Dong M; Kong F; Zhou J
Tumour Biol; 2015 Dec; 36(12):9941-6. PubMed ID: 26178483
[TBL] [Abstract][Full Text] [Related]
23. Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents.
Zou XZ; Zhou XH; Feng YQ; Hao JF; Liang B; Jia MW
Eur J Pharmacol; 2021 Sep; 907():174222. PubMed ID: 34087221
[TBL] [Abstract][Full Text] [Related]
24. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
Oh S; Song H; Freeman WM; Shin S; Janknecht R
Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.
Nazarov IB; Zilov DS; Gordeev MN; Potapenko EV; Yeremenko N; Tomilin AN
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254723
[TBL] [Abstract][Full Text] [Related]
26. [The new isoform of Oct-1 transcription factor is transcribed from alternative promoter].
Krylova ID; Portseva TN; Georgieva SG; Stepchenko AG; Pankratova EV
Mol Biol (Mosk); 2013; 47(4):634-41. PubMed ID: 24466753
[TBL] [Abstract][Full Text] [Related]
27. Post-translational modifications in activation and inhibition of Oct-1-DNA binding complex in H2B and other diverse gene regulation: prediction of interplay sites.
Shakoori AR; Hoessli DC; Nasir-ud-Din
J Cell Biochem; 2013 Feb; 114(2):266-74. PubMed ID: 22961715
[TBL] [Abstract][Full Text] [Related]
28. Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: Transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer.
Katoh Y; Katoh M
Int J Oncol; 2007 Mar; 30(3):751-5. PubMed ID: 17273778
[TBL] [Abstract][Full Text] [Related]
29. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP.
Zwilling S; Annweiler A; Wirth T
Nucleic Acids Res; 1994 May; 22(9):1655-62. PubMed ID: 8202368
[TBL] [Abstract][Full Text] [Related]
30. Zinc finger transcription factor CASZ1 interacts with histones, DNA repair proteins and recruits NuRD complex to regulate gene transcription.
Liu Z; Lam N; Thiele CJ
Oncotarget; 2015 Sep; 6(29):27628-40. PubMed ID: 26296975
[TBL] [Abstract][Full Text] [Related]
31. Histone demethylase JMJD1A in cancer progression and therapeutic resistance.
Jeon HY; Ryu H; Pornour M; Qi J
Mol Carcinog; 2022 Apr; 61(4):392-396. PubMed ID: 35020958
[TBL] [Abstract][Full Text] [Related]
32. Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer.
Yamamoto S; Takayama KI; Obinata D; Fujiwara K; Ashikari D; Takahashi S; Inoue S
Cancer Sci; 2019 Nov; 110(11):3476-3485. PubMed ID: 31454442
[TBL] [Abstract][Full Text] [Related]
33. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
34. POU domain factors in neural development.
Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
[TBL] [Abstract][Full Text] [Related]
35. Sequential expression of multiple POU proteins during amphibian early development.
Hinkley CS; Martin JF; Leibham D; Perry M
Mol Cell Biol; 1992 Feb; 12(2):638-49. PubMed ID: 1732736
[TBL] [Abstract][Full Text] [Related]
36. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
[TBL] [Abstract][Full Text] [Related]
37. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
[TBL] [Abstract][Full Text] [Related]
38. The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.
Cho HS; Toyokawa G; Daigo Y; Hayami S; Masuda K; Ikawa N; Yamane Y; Maejima K; Tsunoda T; Field HI; Kelly JD; Neal DE; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R
Int J Cancer; 2012 Aug; 131(3):E179-89. PubMed ID: 22020899
[TBL] [Abstract][Full Text] [Related]
39. Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex.
Sen S; Sanyal S; Srivastava DK; Dasgupta D; Roy S; Das C
J Biol Chem; 2017 Dec; 292(50):20362-20378. PubMed ID: 29042441
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy.
Ho KH; Shih CM; Liu AJ; Chen KC
Cancer Sci; 2022 Feb; 113(2):540-552. PubMed ID: 34897892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]